12
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Natural Killer Cell Activity in Hepatocellular Carcinoma: In Vitro and in Vivo Responses to Interferon

, &
Pages 1245-1250 | Received 23 Mar 1987, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Rana Ahmed Youness, Mai Atef Rahmoon, Reem Amr Assal, Asmaa Ibrahim Gomaa, Mohamed Tarif Hamza, Imam Waked, Hend Mohamed El Tayebi & Ahmed Ihab Abdelaziz. (2016) Contradicting interplay between insulin-like growth factor-1 and miR-486-5p in primary NK cells and hepatoma cell lines with a contemporary inhibitory impact on HCC tumor progression. Growth Factors 34:3-4, pages 128-140.
Read now

Articles from other publishers (12)

Nicolas Jacquelot, Cyril Seillet, Fernando Souza-Fonseca-Guimaraes, Adrian G. Sacher, Gabrielle T. Belz & Pamela S. Ohashi. (2021) Natural Killer Cells and Type 1 Innate Lymphoid Cells in Hepatocellular Carcinoma: Current Knowledge and Future Perspectives. International Journal of Molecular Sciences 22:16, pages 9044.
Crossref
Lazar Vujanovic, Elizabeth C. Stahl, Angela D. Pardee, David A. Geller, Allan Tsung, Simon C. Watkins, Gregory A. Gibson, Walter J. Storkus & Lisa H. Butterfield. (2017) Tumor-Derived α-Fetoprotein Directly Drives Human Natural Killer–Cell Activation and Subsequent Cell Death. Cancer Immunology Research 5:6, pages 493-502.
Crossref
Cheng Sun, Haoyu Sun, Cai Zhang & Zhigang Tian. (2014) NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma. Cellular & Molecular Immunology 12:3, pages 292-302.
Crossref
George Notas, Tatiana Kisseleva & David Brenner. (2009) NK and NKT cells in liver injury and fibrosis. Clinical Immunology 130:1, pages 16-26.
Crossref
Stergios Moschos, Sai Varanasi & John M. Kirkwood. 2005. Cytokines and Cancer. Cytokines and Cancer 207 241 .
Man‐Fung Yuen, Clara Gaik‐Cheng Ooi, Chee‐Kin Hui, Wai‐Man Wong, Benjamin Chun‐Yu Wong, Annie On‐On Chan & Ching‐Lung Lai. (2003) A pilot study of transcatheter arterial interferon embolization for patients with hepatocellular carcinoma. Cancer 97:11, pages 2776-2782.
Crossref
Lesley J. Scott & Caroline M. Perry. (2002) Interferon-??-2b Plus Ribavirin. Drugs 62:3, pages 507-556.
Crossref
S Nishiguchi, T Kuroki, S Nakatani, H Morimoto, T Takeda, S Nakajima, S Shiomi, S Seki, K Kobayashi & S Otani. (1995) Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. The Lancet 346:8982, pages 1051-1055.
Crossref
Masayuki Yamamoto, Hidehiko Iizuka, Masanori Matsuda, Kaoru Nagahori, Kazuo Miura & Jun Itakura. (1993) The indications for tumor mass reduction surgery and subsequent multidisciplinary treatments in stage IV hepatocellular carcinoma. Surgery Today 23:8, pages 675-681.
Crossref
Luc Bouwens & Eddie Wisse. (2008) Pit cells in the liver. Liver 12:1, pages 3-9.
Crossref
M.N. Aparicio-Pagés, H.W. Verspaget, A.S. Peña, J.B.M.J. Jansen & C.B.H.W. Lamers. (1991) Natural killer cell activity in patients with neuroendocrine tumours of the gastrointestinal tract; Relation with circulating gastrointestinal hormones. Neuropeptides 20:1, pages 1-7.
Crossref
Wan-Long Chuang, Hong-Wen Liu, Wen-Yu Chang, Shinn-Cherng Chen, Ming-Yuh Hsieh & Liang-Yen Wang. (1991) Natural killer cell activity in patients with liver cirrhosis relative to severity of liver damage. Digestive Diseases and Sciences 36:3, pages 299-302.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.